Tess Burleson - 07 Jun 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/ David J. Arthur, Attorney-in-Fact
Issuer symbol
SLRX
Transactions as of
07 Jun 2022
Net transactions value
+$4,986
Form type
4
Filing time
08 Jun 2022, 15:14:30 UTC
Previous filing
21 Jan 2022
Next filing
05 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $4,986 +27,700 +637% $0.1800 32,050 07 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.